Volume 26, Issue 1 (Spring 2022)                   2022, 26(1): 19-26 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Faghany Baladehi R, Bazmani A, Ahangar Oskouee M, Jafari Sales A, Pirzadeh T, Shokouhi B, et al . Frequency of Human Papilloma Virus 16/18 Patients With Prostate Cancer by Polymerase Chain Reaction Method in Hospitals of Tabriz City, Iran. Journal of Inflammatory Diseases. 2022; 26 (1) :19-26
URL: http://journal.qums.ac.ir/article-1-3284-en.html
1- Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
2- Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
3- Department of Microbiology, School of Medical Sciences, Islamic Azad University, Kazerun, Iran.
4- Department of Bacteriology, School of Medicine, Tabriz University of Medical, Sciences, Tabriz, Iran.
5- Department of Pathology, Tabriz University of Medical Sciences, Tabriz, Iran.
6- Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. , hbannazadeh@tbzmed.ac.ir
Abstract:   (1560 Views)
Background: Prostate cancer (PCa), as the fifth leading cause of death, is the second most common cancer diagnosis in men worldwide. Human papillomavirus (HPV) can potentially contribute to PCa development and chronic inflammation. HPV infection leads to malignant and benign lesions in the genital areas of men and women. The data on the role of HPV in PCa development is contradictory. 
Objective: This study aims to investigate the frequency of HPV in PCa samples in hospitals in Tabriz City, Iran.
Methods: This study was conducted in a cross-sectional descriptive manner. Paraffin tissue blocks including 50 patients with primary prostate adenocarcinoma and 50 patients with benign prostatic hyperplasia (BPH) were selected from Tabriz hospitals. All samples were examined for the presence of HPV16/18 by the polymerase chain reaction (PCR) method.
Findings: 3 out of 50 PCa patients are infected with HPV18. None of the benign and malignant prostate samples are infected with HPV 16. Therefore, in our study, no connection exists between HPV and PCa. The Mean±SD age of HPV positive samples was 61.33±11.50 years.
Conclusion: The result of this research does not support the role of HPV in the development of PCa. Therefore, additional studies are necessary to clarify the possible role of HPV in prostate carcinogenesis.
Full-Text [PDF 593 kb]   (826 Downloads) |   |   Full-Text (HTML)  (46 Views)  
Type of Study: Research | Subject: Virology

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Journal of Inflammatory Diseases

Designed & Developed by : Yektaweb